Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
liver transplant
BGF exits Oxford medtech OrganOx in $1.5B deal
By
Jessica Hagen
|
12:57 pm |
August 25, 2025
British Growth Fund’s exit marks one of the largest for a UK medtech company and the most profitable return in the firm’s history.